Abstract Background The Atrial Fibrillation Better Care (ABC) has been proposed as an
integrated approach to improve management in patients with atrial fibrillation (AF), based on …

We aimed to assess the association between SBP-VVV and outcomes in Asian patients with
atrial fibrillation (AF). AF patients in the COOL-AF registry with SBP measured at baseline …

Objective To validate a single-lead electrocardiogram algorithm for identifying atrial
fibrillation, atrial premature beats, ventricular premature beats, and sinus rhythm. Methods A …

Real-world data on effectiveness and safety of a single non-vitamin K antagonist oral
anticoagulant in the Chinese population with atrial fibrillation (AF) are limited. This study …

Edoxaban, a once-daily, direct-acting oral anticoagulant, is approved to prevent stroke or
systemic embolism in non-valvular atrial fibrillation (NVAF) and treat venous …

Background: To analyze the impact of using different renal function equations and stroke
prevention strategy in atrial fibrillation (AF) across all chronic kidney disease (CKD) stages …

Background Evidence of the pharmacodynamics of direct oral anticoagulants (DOACs) is
limited in patients with atrial fibrillation (AF) and liver cirrhosis (LC). This study aimed to …

To explore the anticoagulant effect and safety of utilizing different doses of rivaroxaban for
the treatment of patients with atrial fibrillation (AF) in the real world. A retrospective case …

背景直接口服抗凝药物(DOACs) 逐渐替代维生素K 拮抗剂华法林, 成为非瓣膜性心房颤动抗凝
治疗的首选药物, 但其临床使用的安全性和有效性需要持续关注. 目的通过调查分析心内科住院 …

BACKGROUND: The clinical characteristics and long-term outcomes of patients with
ischemic stroke (IS) and newly diagnosed atrial fibrillation after stroke (NAF) have not been …